Q3 FY2026 Earnings
Financial report interval: 2026.05.01 - 2026.07.31
Overview: Clearmind Medicine(CMND) the EBIT is -2.18 M (-54.85%);the EPS is -0.573 (+99.41%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B54.85%
----
----
EPS
-0.573499.41%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf